Spinal Metastases Clinical Trial
Official title:
Quantitative MR Imaging Methods for Functional Assessment Following Stereotactic Body Radiation Therapy for Spinal Metastases
The purpose of this study is to determine if quantitative magnetic resonance imaging (qMRI) can objectively measure changes in the tumor/vertebral body and adjacent spinal cord following stereotactic body radiation therapy (SBRT) for painful metastatic spine disease.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - A diagnosis of metastatic cancer with a vertebral body metastasis or contiguous vertebral body metastases for which SBRT is appropriate - Age = 18 years of age - KPS = 70 - Life expectancy of at least 3 months - No contraindication to undergoing MR imaging - Women of childbearing age must have a negative urine or serum pregnancy test to meet eligibility per Duke Policy - Pre-treatment pain score of at least 1/10 based on the numeric pain rating scale (NPRS) - Disease located from C1 to S5 - Subjects with prior radiation to the involved vertebral body are allowed. Exclusion Criteria: - Subjects unable to undergo MRI (includes non-MRI compatible material or devices and severe claustrophobia) - Subjects with prior procedural intervention to the involved vertebral body that would result in artifact (kyphoplasty, screw and/or rod placement); minimally invasive surgery without instrumentation of the involved vertebral body and instrumentation immediately above or below the index lesion is allowed. - Subjects with spinal cord compression; minimally invasive "separation" surgery to first resect the epidural component is allowed - Pregnant or breast-feeding women - Allergy to standard IV contrast agents used in MRI - Subjects with eGFR <30 30 mL/min2 or on dialysis |
Country | Name | City | State |
---|---|---|---|
United States | Duke Cancer Center | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Relative Change in Sequence specific parameters for Diffusion tensor imaging (DTI) | baseline, 4 wks | ||
Primary | Relative Change in Sequence specific parameters for Diffusion weighted imaging (DWI) | baseline, 4 wks | ||
Primary | Relative Change in Sequence specific parameters for Dynamic contrast enhanced (DCE) MRI | baseline, 4 wks | ||
Secondary | Change in numeric pain score as measured by the Numeric Pain Rating Scale | Measured from 0-10 with 0 being no pain and 10 being severe pain | baseline, 4 wks | |
Secondary | Change in numeric pain score as measured by the Brief Pain Inventory | Measured from 0-10 with 0 being no pain and 10 being worst imaginable pain | baseline, 4 wks | |
Secondary | Change in numeric pain score as measured by the EQ5D Pain Questionnaire | Measured from 0-10 with 0 being no pain and 10 being worst imaginable pain | baseline, 4 wks | |
Secondary | Change in opioid use | baseline, 4 wks | ||
Secondary | Change in quality of life as measured by the Pat Sf36 V2 assessment | Pat SF36 V2 is a quality of life survey about physical activity, general health and daily functions measured from excellent/much better/yes, limited a lot/all of the time/not at all, through poor/much worse/no,not limited at all/none of the time/extremely with additional not answered option | baseline, 4 wks | |
Secondary | Change in quality of life as measured by the PROMIS assessment | PROMIS categories include physical function, anxiety, depression, fatigue, sleep and pain ranging from never/not at all through always/very much. | baseline, 4 wks | |
Secondary | Change in quality of life as measured by the SOSG+ assessment | Questionnaire about physical function, neurological function and pain ranging from never/not at all through always/very much | baseline, 4 wks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01347307 -
Stereotactic Body Radiotherapy for Spine Tumors
|
N/A | |
Terminated |
NCT00593320 -
Stereotactic Radiosurgery (SRS) for Spine Metastases
|
N/A | |
Recruiting |
NCT05575323 -
Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases
|
N/A | |
Completed |
NCT02987153 -
Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study
|
N/A | |
Recruiting |
NCT03363685 -
Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis
|
||
Terminated |
NCT02407795 -
Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases
|
N/A | |
Completed |
NCT01365715 -
Preoperative Embolization in Surgical Treatment of Spinal Metastases.
|
N/A | |
Recruiting |
NCT04863612 -
SBRT in the Management of Solid Spinal Metastases
|
||
Recruiting |
NCT04242589 -
Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions
|
Phase 2 | |
Recruiting |
NCT01849510 -
Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost
|
Phase 2 | |
Not yet recruiting |
NCT06244264 -
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
|
N/A | |
Not yet recruiting |
NCT06220071 -
Multicentric European Study In Patients With Vertebral Metastases
|
||
Completed |
NCT01290562 -
Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)
|
Phase 2 | |
Recruiting |
NCT06120426 -
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
|
||
Completed |
NCT03224650 -
Validation of Novel Predictive Score for Patients With Spinal Metastases
|
||
Completed |
NCT02512965 -
Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases
|
N/A | |
Not yet recruiting |
NCT06093854 -
Intraoperative Radiotherapy in Treating Spinal Metastases
|
N/A | |
Completed |
NCT02364115 -
Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL Study
|
N/A | |
Recruiting |
NCT03398915 -
The European Robotic Spinal Instrumentation (EUROSPIN) Study
|
||
Not yet recruiting |
NCT05173467 -
Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor
|
N/A |